Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people

European Journal of Cancer

Volumn 46, Issue 16, 2010, Pages 2950-2964

  Phillips, Bob ^a   Wade, Ros ^a   Stewart, Lesley A ^a   Sutton, Alex J ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Clinical decision rules; Diagnosis; Meta analysis; Neutropaenic sepsis; Systematic review

Indexed keywords

CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; FEBRILE NEUTROPENIA; HUMAN; MEDICAL DECISION MAKING; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 78049292233     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.05.024     Document Type: Article

References (45)

1. K. Pritchard-Jones, P. Kaatsch, E. Steliarova-Foucher, C.A. Stiller, and J.W.W. Coebergh Cancer in children and adolescents in Europe: developments over 20 years and future challenges European Journal of Cancer 42 13 2006 2183 2190
2. F. Freycon, and B. Trombert-Paviot Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rh"ne-Alpes region in France (ARCERRA) Pediat Blood Cancer 50 6 2008 1213 1220
3. D.R. Hargrave, and I.M. Hann Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI) Brit J Haematol 112 2 2001 293 299
4. I. Hann, C. Viscoli, M. Paesmans, H. Gaya, and M. Glauser A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC) Br J Haematol 99 3 1997 580 588
5. B. Phillips, K. Selwood, and S.M. Lane Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres Arch Dis Child 92 6 2007 495 498
6. M. Boragina, and H. Patel Management of febrile neutropenia in pediatric oncology patients: a Canadian survey Pediat Blood Cancer 48 5 2007 521 526
7. T.G. McGinn, G.H. Guyatt, and P.C. Wyer Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group JAMA 284 1 2000 79 84
8. J. Klastersky, M. Paesmans, and E.B. Rubenstein The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients J Clin Oncol: Off J Am Soc Clin Oncol 18 16 2000 3038 3051
9. Vidal L, Paul M, Ben-Dor I, et al. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database of Systematic Reviews (Online) 2004(4):CD003992-CD003992.
10. Centre for Reviews and Dissemination. Systematic review: CRD's guidance for undertaking reviews in health care. York: University of York; 2009.
11. J.G. Lijmer, B.W. Mol, and S. Heisterkamp Empirical evidence of design-related bias in studies of diagnostic tests JAMA 282 11 1999 1061 1066
12. P. Whiting, A. Rutjes, J. Reitsma, P. Bossuyt, and J. Kleijnen The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 1 2003 25-25
13. Centre for Reviews and Dissemination. Systematic reviews of clinical tests. In: Centre for Reviews and Dissemination, editor. Systematic review: CRD's guidance for undertaking reviews in health care. York: University of York; 2009. p. 127.
14. Harbord R. METANDI: Stata module to perform meta-analysis of diagnostic accuracy. In. S456932 ed: Department of Social Medicine, University of Bristol; 2008.
15. D.L. Simel, and P.M. Bossuyt Differences between univariate and bivariate models for summarizing diagnostic accuracy may not be large J Clin Epidemiol 62 12 2009 1292 1300
16. S. Goodacre, A.J. Sutton, and F.C. Sampson Meta-analysis: the value of clinical assessment in the diagnosis of deep venous thrombosis Ann Intern Med 143 2 2005 129 139
17. D. Lunn, A. Thomas, N. Best, and D. Spiegelhalter WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility Stat Comput 10 4 2000 337 325-337, 325
18. V. Dukic, and C. Gatsonis Meta-analysis of diagnostic test accuracy assessment studies with varying number of thresholds Biometrics 59 4 2003 936 946
19. K.G. Adcock, R.L. Akins, and E.A. Farrington Evaluation of empiric vancomycin therapy in children with fever and neutropenia Pharmacotherapy 19 11 1999 1315 1320
20. S.W. Alexander, K.C. Wade, P.L. Hibberd, and S.K. Parsons Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer J Pediatr Hematol/Oncol 24 1 2002 38 42
21. R.A. Ammann, A. Hirt, A.R. Luthy, and C. Aebi Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection Med Pediatr Oncol 41 5 2003 436 443
22. E.P. Baorto, V.M. Aquino, C.A. Mullen, G.R. Buchanan, and M.R. DeBaun Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia Cancer 92 4 2001 909 913
23. S. Gala Peralta, T. Cardesa Salzman, and J.J. Garcia Garcia Bacteraemia risk criteria in the paediatric febrile neutropenic cancer patient Clin Transl Oncol 7 4 2005 165 168
24. I. Hann, C. Viscoli, M. Paesmans, H. Gaya, and M. Glauser A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC) Br J Haematol 99 3 1997 580 588
25. G.R. Jones, G.K. Konsler, R.P. Dunaway, and S.N. Pusek Infection risk factors in febrile, neutropenic children and adolescents Pediatr Hematol Oncol 13 3 1996 217 229
26. R.J. Klaassen, T.R. Goodman, B. Pham, and J.J. Doyle "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia J Clin Oncol 18 5 2000 1012 1019
27. K.G. Lucas, A.E. Brown, D. Armstrong, D. Chapman, and G. Heller The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis Cancer 77 4 1996 791 798
28. K. Madsen, M. Rosenman, S. Hui, and P.P. Breitfeld Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia J Pediatr Hematol/Oncol 24 4 2002 256 262
29. H.R. Paganini, C. Aguirre, and G. Puppa A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer Cancer 109 12 2007 2572 2579
30. A.S. Petrilli, R. Melaragno, and A. Bianchi Fever and neutropenia in children with cancer: a new therapeutic proposal Amb; Rev Assoc Med Bras 37 4 1991 173 180
31. P.I.P. Rondinelli, K.d.C.B. Ribeiro, and B. de Camargo A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia J Pediatr Hematol/Oncol 28 10 2006 665 670
32. M.E. Santolaya, A.M. Alvarez, and C.L. Avils Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia Clinical Infectious Diseases 35 6 2002 678 683
33. M.E. Santolaya, A.M. Alvarez, and A. Becker Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever J Clin Oncol 19 14 2001 3415 3421
34. G. Tezcan, A. Kupesiz, and F. Ozturk Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey Pediatr Hematol Oncol 23 3 2006 217 229
35. D.C. West, J.P. Marcin, and R. Mawis Children with cancer, fever, and treatment-induced neutropenia: risk factors associated with illness requiring the administration of critical care therapies Pediatr Emerg Care 20 2 2004 79 84
36. W.R. Rackoff, R. Gonin, C. Robinson, S.G. Kreissman, and P.B. Breitfeld Predicting the risk of bacteremia in children with fever and neutropenia J Clin Oncol 14 3 1996 919 924
37. P. Riikonen, H. Jalanko, L. Hovi, and U.M. Saarinen Fever and neutropenia in children with cancer: diagnostic parameters at presentation Acta Paediatr Int J Paediatr 82 3 1993 271 275
38. L.C. Rojo, Z.N. Rodriguez, and C.J. Tordecilla Low risk febrile neutropenia in oncological pediatric patients: clinical experience [Spanish] Rev Chilena Pediatr 79 2 2008 157 162
39. E. Rivers, B. Nguyen, and S. Havstad Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 19 2001 1368 1377
40. E.W. Steyerberg, M.J. Eijkemans, F.E. Harrell Jr., and J.D. Habbema Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets Stat Med 19 8 2000 1059 1079
41. P. Royston, and W. Sauerbrei Multivariable model - building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables 2008 John Wiley & Sons Inc. (E)
42. R.S. Watson, J.A. Carcillo, and W.T. Linde-Zwirble The epidemiology of severe sepsis in children in the United States Am J Respir Crit Care Med 167 5 2003 695 701
43. D.G. Altman, B. Lausen, W. Sauerbrei, and M. Schumacher Dangers of using "optimal" cutpoints in the evaluation of prognostic factors J Natl Cancer Inst 86 11 1994 829 835
44. R.D. Riley, K.R. Abrams, and A.J. Sutton Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future Br J Cancer 88 8 2003 1191 1198
45. Phillips R. Predicting infectious complications in febrile neutropenic children with cancer (PICNICC). [accessed May 2010].